Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer

Clinical trial NCT00026338 · COMPLETED

Trial details

NCT number: NCT00026338
Sponsor: NCIC Clinical Trials Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2001-10-29
Primary completion: 2004-09-17
Enrollment: 569

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.